Independently, an optimized gene was produced from expression from the pET28a plasmid with a simple N-terminal His-tag and the first 20 residues of the natural protein deleted, to produce the protein designated TxGH116-N. This protein was crystallized and the crystals diffracted to determine the structure in the P61 space group. Notably, although the monomer this structure was quite similar to the P21212 space group structure of TxGH116D18, the loop containing the catalytic acid/base had shifted approximately 2 Å to move the catalytic acid/base further from the catalytic nucleophile, thereby indicating the flexibility of this loop.
Structural comparison:
TxGH116 shows no structural similarity to other retaining -glucosidases. The glycoside hydrolase (GH) clan GH-A families, including GH1, GH2, GH5, and GH30, possess (/)8-barrel catalytic domains, while the active site in family GH3 is located between a (/)8-barrel and a -sandwich domain ( Figure S2A ). Superposition of the catalytic nucleophiles, and covalently-linked sugar-like inhibitors (G2F in the case of TxGH116), from structural representatives of these families reveals a unique position for the general acid/base of TxGH116, above carbons 3 and 4 of the pyranose ring, whereas in clan GH-A enzymes (comprising GH1, 5 and 30) it is located lateral to the ring on the C1-C2 bond side, and in GH3 enzymes is located above the C2-O2 bond ( Figure S2B ). In addition to the unique position of the general acid/base in TxGH116, the surrounding residues that interact with the glucosyl residue are completely different from those in the GH30 GBA1 ( Figure  S2C ), yet are completely conserved between TxGH116 and GBA2 ( Figure 3C ). This unique active site structure may allow design of inhibitors for GBA2 that have little effect on GBA1 and other human -glucosidases.
The overall structures of the Geobacillus thermoglucosidaseus GH family 52 -xylosidase (GtGH52) 3 and Thermoanaerobacterium xylanolyticum TxGH116 -glucosidase are compared in Figure S3 . These two structures share the same gross folds and domain structures, but differ in many details. The GtGH52 N-terminus is significantly shorter and lacks the first helix and the long loop that follows it and contributes to the active site cleft in TxGH116. The first small -sheet is 2 strands in GtGH52 and 3 strands in TxGH116, while the smaller of the two sandwiched -sheets has 6 strands in GtGH52, compared to 5 in TxGH116, due to inclusion of a short parallel -strand on the end not found in TxGH116. A few short -sheets are also found toward the end of the N-terminal domain and between the helices of the C-terminal domain in GtGH52, and are significantly displaced from the positions in TxGH116. Interestingly, although the structure of the long loop between the fifth and sixth loops that contains the catalytic acid/base is not very similar in overall structure, it contains a metal binding site (modeled as sodium in GtGH52) in nearly the same position as the metal site in TxGH116, as well as having the catalytic acid/base in a similar position. Although GtGH52 -xylosidase is a retaining enzyme, Espina et al. 3 noted that it shares significant structural similarity to inverting glycosidases and phosphorylases from families GH15, GH63, GH65, GH78, GH92, GH94, and GH95, a similarity shared with TxGH116.
Evidence of catalytic mechanism and amino acid residues
Since the putative catalytic residues for TxGH116 were considerably further apart than previously characterized retaining glycosidases, (8 Å in the P21212 structure and >10 Å in the P61 structure vs. 4.5-6.5 Å in other retaining -glucosidases), we sought to verify the retaining mechanism and catalytic residues. A time-course NMR study of the hydrolysis of 4NPGlc indeed showed that the initial sugar product was -D-glucose ( Figure S5A ), thereby verifying that TxGH116, like other members of this family, uses a retaining mechanism. The catalytic activity of the TxGH116 variant E441A for hydrolysis of 4NPGlc was reduced by 50,000-fold relative to wild type (Table 1) , and was rescued in a concentration-dependent manner by addition of formate or azide to give maximal enhancement of 1000-fold with 4 M formate ( Figure S5B ). Figure S5E ), as expected for rescue of a nucleophile mutant with a retaining mechanism ( Figure S4B ). 4 Consistent with the role of D593 as an acid/base, the variant D593A possessed activity 39,000-fold lower than wild type on cellobiose, a substrate that requires general acid catalysis for the glycosylation step, but only 350-fold lower activity on 4NPGlc, which requires less protonic assistance ( Table 1 ). The activity of the D593A variant on 4NPGlc was enhanced approximately 10-fold with 4 M formate and 2-fold with sodium azide ( Figure S5C ). In this case, the product with azide was -glucosyl azide (H1: δ 4.62 ppm, d, J1,2 = 8.6 Hz; Figure S5F ), again consistent with the retention of anomeric configuration expected for rescue of an acid/base mutant ( Figure S4C) . 4 Collectively, these data support the assignment of E441 as the catalytic nucleophile and D593 as the general acid/base.
The computed free energy landscape analysis of glucoimidazole indicates that the barriers to adopting transition state mimicking planar conformations (half-chair, boat and envelope) are low and that the conformation observed on enzyme likely reflects the preference imposed by the enzyme.
5
Taken together, the 4 C1 conformation of the G2F complex can be considered to reveal the conformation of the glycosyl enzyme intermediate, and the GIM complex the conformation of the transition state, allowing proposal of a
C1 conformational itinerary for the glycosylation half reaction for GH116 enzymes, similar to that for other retaining -glucosidases.
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Supplemental Methods
Plasmid construction
For the TxGH1161-18 construct, the previously described construct for full-length TxGH116 in pET30a
1 was used as the template to PCR amplify the sequence encoding the TxGH116 without the stop codon with the primers T7_fwd and TxGH116_no_stop_rev, without the first 18 amino acids and the stop codon with the primers TxGH116_19_fwd and TxGH116_no_stop_rev, without the first 157 amino acids and the stop codon with the primers TxGH116_158_fwd and TxGH116_no_stop_rev, and without the first 400 amino acid residues and missing the stop codon primers TxGH116_401_fwd and TxGH116_no_stop_rev. The amplified DNA product bands were purified and cloned back into the pET30a plasmid to encode proteins that each contained an N-terminal His-tag, thrombin site, S-tag, and enterokinase site, and a C-terminal His-tag.
For the TxGH116-N construct, the gene encoding the GH116 protein from Thermoanaerobacterium xylanolyticum was purchased in a form codon optimised for E. coli expression. The gene was provided cloned into pET28a (30 g/ml kanamycin resistant) between NdeI and XhoI restriction sites.
Protein expression
The pET30a/TxGH116 plasmids were transformed into BL21(DE3) E. coli and expressed at 20 °C and proteins extracted in lysis buffer as previously described for a related construct encoding the fulllength TxGH116. 1 After induction with 0.3 mM IPTG at 20ºC for 16-18 h, the proteins were extracted and the soluble fraction evaluated for hydrolysis of 4-nitrophenyl -D-glucopyranoside (4NPGlc) and by SDS-PAGE. Fractions with activity were further heated at 50ºC 20 min, then 70ºC 20 min, with insoluble protein removed by centrifugation after each step, and the soluble protein evaluated by the same methods. For production of selenomethionine-labeled TxGH116 (SeTxGH116), the pET30a/TxGH1161-18 plasmid was transformed into E. coli strain B834(DE3) pLysS cells, and grown in SeMet core medium (Nihon Jyunyaku Co.) consisting of 10 g D-glucose, 20 g maltose monohydrate, 250 mg MgSO4.7H2O, 4.175 mg FeSO4
. 7H2O, 5 mg thiamine, 8.3 µL H2SO4, 50 mg ampicillin, 34 mg chloramphenicol, and 25 mg SeMet per liter. The cells were cultured at 37°C to achieve OD600 0.5-0.6 and then induced with 0.3 M IPTG at 20ºC for 18 h.
After heating at 70ºC, the soluble extract of TxGH1161-18 was purified by immobilized metal affinity chromatography (IMAC) on TALON cobalt affinity resin (Clontech). After washing with equilibration buffer (150 mM NaCl, 20 mM sodium phosphate, pH 7.4) and 5 mM and 10 mM imidazole in equilibration buffer, the specific protein was eluted with 250 mM imidazole in equilibration buffer. The 250 mM imidazole fraction containing TxGH116 protein was concentrated and the buffer exchanged to 150 mM NaCl, 20 mM Tris, pH 8.0. The protein was digested with 0.006 g enterokinase (New England Biolabs) per mg protein at 23 ºC for 18 h, then purified over a Superdex S200 gel filtration column in 500 mM NaCl, 20 mM Tris, pH 8.0. Fractions containing TxGH116 were pooled and the buffer exchanged to 150 mM NaCl, 20 mM Tris, pH 8.0, in a Centricon 30 kDa MWCO centrifugal filter (Millipore Corp.). For production of TxGH116-N, The pET28a/TxGH116 plasmid was transformed into E. coli strain BL21(DE3) and the expression of the TxGH116 gene induced with 0.5 mM IPTG at 16 °C for 18 h. Proteins were extracted by sonication at 14-18 Hz, four runs of 40-50 s exposure, in buffer A (50 mM HEPES pH 7.5, 500 mM NaCl, 20 mM imidazole). The soluble fraction of TxGH116-N was purified by nickel affinity chromatography on a 5 ml GE Healthcare HisTrap column, eluted with a gradient into buffer B (50 mM HEPES pH 7.5, 500 mM NaCl, 500 mM imidazole). The fractions containing TxGH116-N were pooled, concentrated and buffer exchanged into 50 mM HEPES, pH 7.5, 500 mM NaCl. The protein was then purified over a Superdex S200 gel filtration column in 50 mM HEPES pH 7.5, 500 mM NaCl and the fractions containing TxGH116 pooled, concentrated to 20 mg/ml in a 50 kDa MWCO centrifugal filter (Millipore Corp.) and stored at 5 °C.
Solution Analysis: Size Exclusion Chromatography -Multi-Angle Laser Light Scattering (SEC-MALLS) was used to determine the molecular mass of soluble-state TxGH116-N. A Superdex 200 HR 10/30 column was connected to an HPLC system, which was coupled to a DAWN Heleos light scattering instrument with a laser wavelength of 658.00 nm (Wyatt Technology). TxGH116-N (250 nmol) was run in buffer containing 50 mM HEPES, pH 7.5, 500 mM NaCl at 0.5 ml/min and the absolute masses of the particles in the solution determined with Wyatt software. Soluble TxGH116-N showed a major peak at a molar mass determined to be 1.66  10 5 g/mol, corresponding with the predicted mass of dimeric TxGH116-N ( Figure S1C) .
Confirmation of the anomeric configurations of the glucose product of TxGH116 and glucosyl azides produced in rescue of catalytic residue mutants:
To check the anomeric configuration of glucose product, the enzyme TxGH1161-18 was exchanged with phosphate buffer in deuterium water (pH 6, 10 mM) three times before running NMR experiments. For 4NPGlc hydrolysis experiment, 7.3 mM 4NPGlc and 50 μM TxGH1161-18 were prepared in an NMR tube and the proton spectra collected before adding enzyme and after 10 min, 30 min. and overnight reactions.
TxGH1161-18 wild type (0.22 µM), D593A (11 µM) and E441A (44 µM) were incubated with 5 mM 4NPG and 50 mM azide in 50 mM MES buffer pH 5.5. The reactions were incubated at 60 ºC, 1 h for TxGH116 wild type and D593A, and 18 h for E441A. The reactions were terminated by boiling for 5 min. Samples were centrifuged at 13,000 rpm for 10 min and then applied to silica gel thin layer chromatography (TLC) plates ( Figure S5D ). Plates were developed with chloroformMeOH-NH4OH (7:2.8:0.2), and products detected using (a) UV light or (b) by exposure to 10% sulfuric acid in ethanol followed by charring.
For NMR analysis, 2 mL reactions were separated by silica gel TLC, as described above and the silica gel from the region of the product band was scraped off and eluted with 30% methanol, dried and redissolved in 100% methanol and the supernatant dried for NMR. The purified glucosyl azides were dissolved in acetone-d6 and proton NMR spectra were performed on a 500 MHz NMR spectrometer (Bruker AVANCE III HD, Germany) with a CPP BBO 500 Cyroprobe. The 1 H NMR spectra were collected at a frequency of 500.366 MHz. The glucopyranosyl azide obtained from mutant D593A was confirmed as β-glucopyranosyl azide, its 1 H NMR were assigned as: δ4.62 (H1, d, J2,1=8.6 Hz), δ 3.93 (H6, dd, J5,6 = 2.2 Hz, J6,6'=11.9 Hz), δ 3.77 (H6', dd, J5,6' = 5.2 Hz, J6,6'=11.9 Hz), δ 3.44-3.53 (H3, H4, H5, m), δ 3.28 (H2, t, J1,2= J3,2 =8.7 Hz). The 1 H NMR spectrum matched the published for β-glucopyranosyl azide.
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The glucopyranosyl azide obtained from mutant E441A was confirmed as α-glucopyranosyl azide, its 1 H NMR were assigned as: δ5.48 (H1, d, J2,1=3.3 Hz), δ 3.87 (H6, dd, J5,6 = 2.6 Hz, J6,6'=11.7 Hz), δ 3.77 (H6', dd, J5,6' = 5.0 Hz, J6,6'=11.7 Hz), δ 3.63-3.74 (H3, H4, H5, m), δ 3.44 (H2, t, J1,2= J3,2 =6.6 Hz). The 1 H NMR spectrum was similar to the reported for α-glucopyranosyl azide.
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Both α-and β-glucopyranosyl azides were injected into Bruker micrO-TOF-Q mass spectrometer (Q-TOF) to determine their mass spectra. The substrates dissolved in acetone-d6 (containing 0.1% formic acid) were injected directly to Electrospray ionization (ESI) source of Q-TOF mass spectrometer. The ESI source was performed at negative mode, the scan range of mass detector was 50-1500 m/z. The similar mass spectra were obtained for both azides. , which was consisted with the reported data.
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Supplementary Table   Table S1 Oligonucleotide primers used for cloning and mutagenesis. To confirm the existence of calcium ions, purified TxGH116 was analyzed by X-ray fluorescence. A dried sample was scanned using a Cartesian geometry energy dispersive X-ray fluorescence spectrometer, Rigaku NEX CG. A characteristic Ca-Kα peak was detected showing the presence of Ca 2+ ion in the sample. (B) Superposition of TxGH116 P21212 and P61 structures showing the conserved interface between two symmetry mates in the P21212 structure (green) and the A and B molecules of the asymmetric unit of the P61 structure (cyan). The P61 A molecule is nearly perfectly matched to the P21212 structure, to which it was superimposed, while the B molecule is only roughly aligned with the P21212 symmetry mate (violet), except at the dimer interface where it is well aligned. (C) Results from SEC-MALLS of TxGH116-N. There are three distinct peaks at 2.74 × 10 5 g/mol, 1.66 ×10 5 g/mol and 8.47 × 10 4 g/mol. TxGH116-N has a predicted mass of 9.27 × 10 4 g/mol. These data suggest that the dimer is the major form, although monomer and multimers exist. Comparison of the overall structure of TxGH116 to other retaining -glucosidases. A GH2 structure is not shown, since no -glucosidase structure from this family has been reported, but the catalytic domain structure of GH2 is similar to that in other GH Clan A families, including GH1, GH5 and GH30, based on GH2 -galactosidase and -mannosidase structures. (B) The stereo image of the superposition of the catalytic nucleophile (Nuc) and covalently linked sugar-like inhibitor show that the acid/base (A/B) of GH116 is in a completely different position in the active site compared to those in families GH1, GH3, GH5, and GH30. The superimposed structures in the stereo view include: TxGH116 2-deoxyfluoroglucosyl enzyme (green carbons) with the structures of human cytoplasmic -glucosidase (GH1) E165Q mutant glucosyl-enzyme (pink, PDB code: 2Z0X), barley exoglucanase 1 (GH3) 2-deoxy-2-fluoroglucosyl enzyme (grey, PDB code: 1IEW), Candida albicans exoglucanase (GH5) 2-deoxy-2-fluoroglucosyl enzyme (dark blue, PDB code: 2PB1), and human GBA1 (GH30) covalently labeled with conduritol -epoxide (cyan, PDB code: 1Y7V). (C) Stereo image of the active sites of TxGH116 (green carbons) and human GBA1 (cyan, GH30, PDB code: 1Y7V) showing the difference in location of the catalytic acid/base and the absence of conserved sugar-binding residues.
Figure S3
Figure S3. Comparison of the three-dimensional structures of TxGH116 -glucosidase and the structurally related GtGH52 -xylosidase. TxGH116 -glucosidase (A) and GtGH52 -xylosidase (B) exhibit similar overall folds. Both structures contain a metal binding site in nearly the same position, which was modeled as Ca 2+ (purple ball) in TxGH116 and Na + (green ball) in GtGH52. 3 The structures shown in (A) and (B) were superimposed in PyMol and the images rendered separately for clarity. Helices are in blue and -strands in yellow. (C) Divergent stereo view of the active site superposition of the TxGH116 complex with Glc (green) with the GtGH52 complex with xylobiose (cyan). The catalytic acid/base (A/B) and nucleophile residues (Nuc) are labeled and other conserved active site residues simply shown. The structures were superimposed based on the catalytic residues and pyranose ring atoms in the glycone-binding site. Figure S7 Sequence alignment of TxGH116 with human GBA2, rice and archaeal GH116 glycosidase sequences. Active site residues are marked with grey arrows at the bottom of the alignment. Catalytic residues are marked with "Nuc" for nucleophile and "A/B" for acid/base. The residues mutated in missense mutations causing ARCA and HSP are marked with red arrows below the alignment. Other conserved residues are shown in black and grey depending on the degree of conservation. The alignment was produced with the MUSCLE algorithm within MEGA 6.
13, 14 The secondary structure of TxGH116 is diagrammed above the alignment as interpreted by EsPriPT 15 and the secondary structures identified in Figure 1 are indicated above these designations (H for helix and S for -sheet, for which multiple strands are marked for each). Small -sheets with no strands more than 2 residues were ignored in our designations. The sequences include those of TxGH116 (NCBI Accession: AEF18218.1), human (Homo sapiens) GBA2 (NCBI: NP 065995.1), rice (Oryza sativa) expressed GH116 protein (NCBI: EEC81952.1), Sulfolobus solfataricus SSO3039 -Nacetylglucosaminidase (NCBI: AAK43141.1) and S. solfataricus SSO1353 -xylosidase/-glucosidase (NCBI: AAK41589.1). The alignment of SSO3039 was manually modified to match the nucleophile assignment of 16 and improve its match to the other sequences. All mutant proteins showed similar circular dichroism spectra to the wild type, suggesting minimal disruption of the structure at 20 °C. Circular dichroism spectra of wild type (WT, TxGH1161-18) and its D508H and D508N mutant proteins (left) and wild type with R544W and R786H mutants (right). The CD spectra and melting curves were determined for enzymes without removal of the Nterminal hexa-histidine and S-tags, since the D508H and D508N mutants were not stable after enterokinase treatment.
